Naslund Medical News

Moving to SBRT for prostate due to COVID-19?

Moving to SBRT for prostate due to COVID-19?

MAR 31, 2020 Healthcare institutions around the world are currently under extraordinary pressure due to the COVID-19 pandemic and the radiotherapy centers are no exception. Organizations like ASTRO and ESTRO have presented recommendations and information on how to...

read more
Marker based IGRT for breast

Marker based IGRT for breast

OCT 10, 2019 Do you also foresee an increased use of fiducial markers in breast? Accelerated Partial-Breast Irradiation (APBI) offers several benefits, including reduced treatment time, reduced health care cost, and spared healthy tissue. The patient group deemed...

read more
HYPO-RT-PC phase 3 trial

HYPO-RT-PC phase 3 trial

SEP 10, 2019 Congratulations to all the 12 Swedish and Danish centers that have contributed to the HYPO-RT-PC phase 3 trial! As the first published randomised trial on ultra-hypofractionated radiotherapy for prostate cancer, Lancet 18 2019, this groundbreaking study...

read more
New study confirms low risk and great marker stability

New study confirms low risk and great marker stability

DEC 13, 2018 We are happy to share this new study about Gold Anchor from the Karolinska University Hospital in Stockholm, Sweden, with you.  In 621 consecutive prostate cancer patients, the frequency of urinary tract infections (UTI) and marker loss was evaluated...

read more